2017 Synthetic Biology: Engineering, Evolution & Design (SEED) June 20-23, 2017Hyatt Regency, Vancouver, British Columbia, Canada SEED 2017 is focused on advances in the science and technology emerging from the field of synthetic biology. This is broadly defined as technologies that accelerate the process of genetic engineering. The conference highlighted new tool development, as well as the application of these tools to...
Commercializing Industrial Biotechnology 2017 September 17-19, 2017THE HILTON SAN DIEGO RESORT & SPAThis 2 day conference on Technology Challenges and Opportunities in Commercializing Industrial Biotechnology will take place at The Hilton San Diego Resort & Spa from September 17th to 19th in Mission Bay San Diego,California. Online Registration is now Open! Register Here
Interview with Michael Betenbaugh, Winner of 2017 D.I.C. Wang Award April 13, 2017AIChE’s Lucy Alexander sat down with 2017 D.I.C. Wang Award winner Michael Betenbaugh to discuss the ways his career has been influenced by “Danny” Wang and what winning this...
Catalyzing Commercialization: Sustainable Production of Bricks Promises to Curb Global Emissions June2017Catalyzing CommercializationbioMASON, a start-up located in Research Triangle Park, NC, has developed a process for “growing” bricks at room temperature rather than firing them in kilns. The process employs bacteria to grow the building materials without emitting greenhouse gases, and without depleting nonrenewable resources.
Profile: Developing Novel Solutions to Improve Patient Care June2017ProfileLonnie Shea, a professor and chair in the Dept. of Biomedical Engineering at the Univ. of Michigan, is an internationally recognized researcher whose work spans the fields of regenerative medicine, biomaterials, and gene and drug delivery. His research seeks to advance technologies and solutions at the interface of engineering and medicine.
Technical Entity Trends: A World Transitioning to Translational Medicine May2017Technical Entity TrendsGabriel Levesque-TremblayThe failure rate for new drugs and therapies under development exceeds 95%. For the other 5%, it takes at least 14 years and more than $1 billion to develop a successful candidate into a product that can be delivered to patients. The field of...